# KJ-TFC-004 Drug-drug Interaction Study

> **NCT02967614** · PHASE1 · COMPLETED · sponsor: **Kukje Pharma** · enrollment: 32 (actual)

## Conditions studied

- Glaucoma
- Eye Diseases
- Ocular Hypertension

## Interventions

- **DRUG:** [A]
- **DRUG:** [B]
- **DRUG:** [A]+[B](1)
- **DRUG:** [A]+[B](2)

## Key facts

- **NCT ID:** NCT02967614
- **Lead sponsor:** Kukje Pharma
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-12
- **Final completion:** 2018-04-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02967614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02967614, "KJ-TFC-004 Drug-drug Interaction Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02967614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*